Atlas Trials

Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT03096847 · COMPLETED

Trial details

NCT number
NCT03096847
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced Metastatic Breast Cancer
Start date
2016-10-24
Primary completion
2018-12-11
Enrollment
502

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.